Search
Search Results
##search.searchResults.foundPlural##
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4074PDF: 1576HTML: 932 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1701PDF: 830HTML: 142 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2207PDF: 957HTML: 1889 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3216PDF: 1608HTML: 422 -
-
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3742PDF: 1465HTML: 482Figures . Eliassian: 217 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2474PDF: 835HTML: 8811Efremov 1: 222Efremov 2: 183 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2437HTML: 268PDF: 863 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1947PDF: 809HTML: 219 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2390PDF: 849HTML: 2452 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1792PDF: 799HTML: 10229Figures 1,2,3: 172 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
1849PDF: 916Html: 311 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1156PDF: 600HTML: 6796 -
-
-
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1105PDF: 483HTML: 226 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3658PDF: 1429HTML: 181 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2150PDF: 1465HTML: 262 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3291PDF: 1953HTML: 7472 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2776PDF: 1112HTML: 11215 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2149PDF: 1574HTML: 261 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6792PDF: 3636HTML: 749 -
-
-
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1518PDF: 386HTML: 205 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2030PDF: 1854HTML: 341 -
-
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3278PDF: 2261HTML: 23318Untitled: 202Untitled: 214Untitled: 228 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3231PDF: 1072HTML: 428 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4456PDF: 1914HTML: 17730 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3724PDF: 1557HTML: 8029Randi Fig: 177 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5126PDF: 1313HTML: 2740Cover letter: 189 -







